LeClair Wealth Partners’s AbbVie ABBV Stock Holding History

LeClair Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$385K	Buy	+1,531	New	+$329K	0.2%	80
2026 Q1	–	Sell	-1,403	Closed	-$321K	–	104
2025 Q4	$321K	Sell	1,403 -21	-1%	-$4.78K	0.19%	75
2025 Q3	$330K	Sell	1,424 -1	-0.1%	-$204	0.21%	66
2025 Q2	$265K	Buy	1,425 +3	+0.2%	+$558	0.18%	81
2025 Q1	$298K	Buy	1,422 +1	+0.1%	+$194	0.21%	76
2024 Q4	$253K	Buy	+1,421	New	+$261K	0.17%	86

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LeClair Wealth Partners's ABBV Position: Q2 2026 in Review

LeClair Wealth Partners opened a new position in AbbVie (ABBV) in Q2 2026: 1,531 shares worth $385K. The stake represents 0.2% of the portfolio and ranks #80 among its holdings. This is a return to the name: LeClair Wealth Partners previously reported a position in ABBV as recently as Q4 2025.

LeClair Wealth Partners first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

LeClair Wealth Partners held 1,531 shares of AbbVie worth $385K as of Q2 2026.
AbbVie was a new LeClair Wealth Partners position in Q2 2026.
AbbVie made up 0.2% of LeClair Wealth Partners's portfolio in Q2 2026, its #80 holding.
LeClair Wealth Partners first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LeClair Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.